OpenURL Connection Search

Select item for more details and to access through your institution.

CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness.
Published in:
International Journal of Laboratory Hematology, 2011, v. 33, n. 1, p. 92, doi. 10.1111/j.1751-553X.2010.01254.x
By:
- GUILLAUME, N.;
- PENTHER, D.;
- VAIDA, I.;
- GRUSON, B.;
- HARRIVEL, V.;
- CLAISSE, J .F.;
- CAPIOD, J. C.;
- LEFRERE, J. J.;
- DAMAJ, G.
Publication type:
Article
Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles.
Published in:
2016
By:
- Reboursiere, Emilie;
- Fouques, H.;
- Maigne, G.;
- Johnson, H.;
- Chantepie, S.;
- Gac, A.;
- Reman, O.;
- Macro, M.;
- Benabed, K.;
- Troussard, X.;
- Damaj, G.;
- Cheze, S.;
- Gac, A C
Publication type:
journal article
Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi’s anemia.
Published in:
Bone Marrow Transplantation, 2000, v. 26, n. 2, p. 215, doi. 10.1038/sj.bmt.1702469
By:
- Yakoub-Agha, I;
- Damaj, G;
- Garderet, L;
- Bonnet, J;
- Devergie, A;
- Esperou, H;
- Ribaud, P;
- Socie, G;
- Gluckman, E
Publication type:
Article
Bone marrow transplantation in severe Glanzmann’s thrombasthenia with antiplatelet alloimmunization.
Published in:
Bone Marrow Transplantation, 2000, v. 25, n. 3, p. 327, doi. 10.1038/sj.bmt.1702139
By:
- Bellucci, S;
- Damaj, G;
- Boval, B;
- Rocha, V;
- Devergie, A;
- Agha, I Yacoub;
- Garderet, L;
- Ribaud, P;
- Traineau, R;
- Socié, G;
- Gluckman, E
Publication type:
Article
Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipients.
Published in:
Bone Marrow Transplantation, 1999, v. 24, n. 4, p. 351, doi. 10.1038/sj.bmt.1701931
By:
- Rosenzwajg, M;
- Fery, N;
- Bons, V;
- Damaj, G;
- Gluckman, E;
- Gluckman, J C
Publication type:
Article
Efficacy of Anakinra for Various Types of Crystal-Induced Arthritis in Complex Hospitalized Patients: A Case Series and Review of the Literature.
Published in:
Mediators of Inflammation, 2015, v. 2015, p. 1, doi. 10.1155/2015/792173
By:
- Aouba, A.;
- Deshayes, S.;
- Frenzel, L.;
- Decottignies, A.;
- Pressiat, C.;
- Bienvenu, B.;
- Boue, F.;
- Damaj, G.;
- Hermine, O.;
- Georgin-Lavialle, S.
Publication type:
Article
Pulmonary Hypertension Associated with Myeloproliferative Disorders: A Retrospective Study of Ten Cases.
Published in:
Respiration, 2008, v. 76, n. 3, p. 295, doi. 10.1159/000112822
By:
- Guilpain, P.;
- Montani, D.;
- Damaj, G.;
- Achouh, L.;
- Lefrère, F.;
- Le Pavec, J.;
- Marfaing-Koka, A.;
- Dartevelle, P.;
- Simonneau, G.;
- Humbert, M.;
- Hermine, O.
Publication type:
Article
Erratum to: High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
Published in:
2013
By:
- Kelaidi, C.;
- Beyne-Rauzy, O.;
- Braun, T.;
- Sapena, R.;
- Cougoul, P.;
- Adès, L.;
- Pillard, F.;
- Lamberto, C.;
- Charniot, J.;
- Guerci, A.;
- Choufi, B.;
- Stamatoullas, A.;
- Slama, B.;
- Renzis, B.;
- Ame, S.;
- Damaj, G.;
- Boyer, F.;
- Chaury, M.;
- Legros, L.;
- Cheze, S.
Publication type:
Correction Notice
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
Published in:
Annals of Hematology, 2013, v. 92, n. 5, p. 621, doi. 10.1007/s00277-013-1686-4
By:
- Kelaidi, C.;
- Beyne-Rauzy, O.;
- Braun, T.;
- Sapena, R.;
- Cougoul, P.;
- Adès, L.;
- Pillard, F.;
- Lambert, C.;
- Charniot, J.;
- Guerci, A.;
- Choufi, B.;
- Stamatoullas, A.;
- Slama, B.;
- Renzis, B.;
- Ame, S.;
- Damaj, G.;
- Boyer, F.;
- Chaury, M.;
- Legros, L.;
- Cheze, S.
Publication type:
Article
Tyrosine Kinase Inhibitors and Solid Tumours: Case Report and Review of the Literature.
Published in:
Pharmacology, 2009, v. 84, n. 1, p. 38, doi. 10.1159/000225970
By:
- Roszkiewicz, F.;
- Garidi, R.;
- Vaida, I.;
- Royer, B.;
- Parcelier, A.;
- Marolleau, J. P.;
- Damaj, G.
Publication type:
Article
Drug Rash with Eosinophilia and Systemic Symptoms after Chlorambucil Treatment in Chronic Lymphocytic Leukaemia.
Published in:
Pharmacology, 2009, v. 83, n. 3, p. 148, doi. 10.1159/000187429
By:
- Vaida, I.;
- Roszkiewicz, F.;
- Gruson, B.;
- Makdassi, R.;
- Damaj, G.
Publication type:
Article
P14.73 Toxicity and outcomes of reduced-dose whole brain radiotherapy as consolidation treatment for patients with CNS lymphoma in real life setting.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii84, doi. 10.1093/neuonc/noz126.308
By:
- Lesueur, P;
- Damaj, G;
- Hoang-Xuan, K;
- Rolland, V;
- Schmitt, A;
- Chinot, O;
- Fabbro, M;
- Agapé, P;
- Chabrot, C;
- Chebrek, S;
- Feuvret, L;
- Stefan, D;
- Soussain, C;
- Houillier, C
Publication type:
Article
Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone Lymphoma.
Published in:
Advances in Hematology, 2014, p. 1, doi. 10.1155/2014/512508
By:
- Schmidt-Tanguy, A.;
- Houot, R.;
- Lissandre, S.;
- Abgrall, J. F.;
- Casassus, P.;
- Rodon, P.;
- Desablens, B.;
- Marolleau, J. P.;
- Garidi, R.;
- Lamy, T.;
- Moles-Moreau, M.-P.;
- Damaj, G.
Publication type:
Article
Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review.
Published in:
2009
By:
- Etienne, A.;
- Gruson, B.;
- Chatelain, D.;
- Garidi, R.;
- Royer, B.;
- Sevestre, H.;
- Marolleau, J. P.;
- Damaj, G.
Publication type:
Case Study
First-line autologous stem cell transplantation in primary CNS lymphoma.
Published in:
European Journal of Haematology, 2005, v. 75, n. 4, p. 288, doi. 10.1111/j.1600-0609.2005.00508.x
By:
- Brevet, M.;
- Garidi, R.;
- Gruson, B.;
- Royer, B.;
- Vaida, I.;
- Damaj, G.
Publication type:
Article
Single-agent thalidomide induces response in T-cell lymphoma.
Published in:
2005
By:
- Damaj, G.;
- Bouabdallah, R.;
- Vey, N.;
- Bilger, K.;
- Mohty, M.;
- Gastaut, J. A.
Publication type:
Book Review
Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center.
Published in:
European Journal of Haematology, 2004, v. 73, n. 6, p. 402, doi. 10.1111/j.1600-0609.2004.00331.x
By:
- Damaj, G.;
- Mohty, M.;
- Vey, N.;
- Dincan, E.;
- Bouabdallah, R.;
- Faucher, C.;
- Stoppa, A. M.;
- Gastaut, J. A.
Publication type:
Article
Monoclonal antibodies and cytomegalovirus infections.
Published in:
2004
By:
- Damaj, G.;
- Charbonnier, A.;
- Bouabdallah, R.;
- Vey, N.;
- Coso, D.;
- Stoppa, A.M.;
- Gastaut, J.A.
Publication type:
Letter
Severe cardiac toxicity after monoclonal antibody therapy.
Published in:
European Journal of Haematology, 2002, v. 68, n. 5, p. 324, doi. 10.1034/j.1600-0609.2002.00712.x
By:
- Damaj, G.;
- Rubio, M;
- Audard, V.;
- Hermine, O.
Publication type:
Article
Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy.
Published in:
European Journal of Haematology, 2002, v. 68, n. 4, p. 233, doi. 10.1034/j.1600-0609.2002.01669.x
By:
- Damaj, G.;
- Lefrère, F.;
- Canioni, D.;
- Rubio, M.T.;
- Radford-Weiss, I.;
- Valensi, F.;
- Varet, B.;
- Hermine, O.
Publication type:
Article
FDG-PET/CT findings in systemic mastocytosis: a French multicentre study.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 13, p. 2013, doi. 10.1007/s00259-015-3117-3
By:
- Djelbani-Ahmed, S.;
- Chandesris, M.;
- Mekinian, A.;
- Canioni, D.;
- Brouzes, C.;
- Hanssens, K.;
- Pop, G.;
- Durieu, I.;
- Durupt, S.;
- Grosbois, B.;
- Besnard, S.;
- Tournilhac, O.;
- Beyne-Rauzy, O.;
- Agapé, P.;
- Delmer, A.;
- Ranta, D.;
- Jeandel, P.;
- Georgin-Lavialle, S.;
- Frenzel, L.;
- Damaj, G.
Publication type:
Article
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 10, p. 1324, doi. 10.1038/bmt.2013.69
By:
- Innes, A J;
- Beattie, R;
- Sergeant, R;
- Damaj, G;
- Foroni, L;
- Marin, D;
- Kanfer, E;
- Mielke, S;
- Milojkovic, D;
- MacDonald, D;
- Pavlu, J;
- Rahemtulla, A;
- Roberts, I;
- Slade, D;
- Bray, E;
- Goldman, J;
- Apperley, J;
- Szydlo, R;
- Dazzi, F;
- Rezvani, K
Publication type:
Article
The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients.
Published in:
Bone Marrow Transplantation, 2006, v. 37, n. 8, p. 725, doi. 10.1038/sj.bmt.1705308
By:
- Lefrère, F.;
- Zohar, S.;
- Ghez, D.;
- Delarue, R.;
- Audat, F.;
- Suarez, F.;
- Hermine, O.;
- Damaj, G.;
- Maillard, N.;
- Ribeil, J. A.;
- Azagury, M.;
- Misbahi, R.;
- Jondeau, K.;
- Cavazzana-Calvo, M.;
- Dal Cortivo, L.;
- Varet, B.
Publication type:
Article
Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis.
Published in:
2005
By:
- Thaunat, O;
- Alyanakian, MA;
- Varnous, S;
- Bors, V;
- Damaj, G;
- Rerolle, JP;
- Jondeau, K;
- Varet, B;
- Gandjbakhch, I;
- Buzyn, A
Publication type:
Letter
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2004, v. 34, n. 1, p. 77, doi. 10.1038/sj.bmt.1704531
By:
- Mohty, M.;
- Boiron, J.M.;
- Damaj, G.;
- Michallet, A.S.;
- Bay, J.O.;
- Faucher, C.;
- Perreau, V.;
- Bilger, K.;
- Coso, D.;
- Stoppa, A.M.;
- Tabrizi, R.;
- Gastaut, J.A.;
- Michallet, M.;
- Maraninchi, D.;
- Blaise, D.
Publication type:
Article
Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome.
Published in:
Bone Marrow Transplantation, 2004, v. 33, n. 5, p. 531, doi. 10.1038/sj.bmt.1704381
By:
- Depil, S.;
- Deconinck, E.;
- Milpied, N.;
- Sutton, L.;
- Witz, F.;
- Jouet, J. P.;
- Damaj, G.;
- Yakoub-Agha,, I.
Publication type:
Article
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Published in:
2004
By:
- Damaj, G.;
- Ivanov, V.;
- Le Brigand, B.;
- D’incan, E.;
- Doglio, M. F.;
- Bilger, K.;
- Faucher, C.;
- Vey, N.;
- Gastaut, J. A.;
- D'incan, E
Publication type:
journal article
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases.
Published in:
Leukemia (08876924), 2009, v. 23, n. 4, p. 673, doi. 10.1038/leu.2008.362
By:
- Itzykson, R.;
- Ayari, S.;
- Vassilief, D.;
- Berger, E.;
- Slama, B.;
- Vey, N.;
- Suarez, F.;
- Beyne-Rauzy, O.;
- Guerci, A.;
- Cheze, S.;
- Thomas, X.;
- Stamatoullas, A.;
- Gardembas, M.;
- Bauduer, F.;
- Kolb, A.;
- Chaury, M. C.;
- Legros, L.;
- Damaj, G.;
- Chermat, F.;
- Dreyfus, F.
Publication type:
Article
Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab.
Published in:
2007
By:
- Royer, B.;
- Vaida, I.;
- Etienne, A.;
- Garidi, R.;
- Damaj, G.;
- Marolleau, J. P.
Publication type:
Case Study
Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia.
Published in:
Leukemia (08876924), 2006, v. 20, n. 5, p. 793, doi. 10.1038/sj.leu.2404170
By:
- Asnafi, V.;
- Rubio, M.-T.;
- Delabesse, E.;
- Villar, E.;
- Davi, F.;
- Damaj, G.;
- Hirsch, I.;
- Dhédin, N.;
- Vernant, J. P.;
- Varet, B.;
- Buzyn, A.;
- Macintyre, E.
Publication type:
Article
Thalidomide therapy induces response in relapsed mantle cell lymphoma.
Published in:
Leukemia (08876924), 2003, v. 17, n. 9, p. 1914, doi. 10.1038/sj.leu.2403058
By:
- Damaj, G.;
- Lefrère, F.;
- Delarue, R.;
- Varet, B.;
- Furman, R.;
- Hermine, O.
Publication type:
Article
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts.
Published in:
2003
By:
- Ribrag, V;
- Suzan, F;
- Ravoet, C;
- Feremans, W;
- Guerci, A;
- Dreyfus, F;
- Damaj, G;
- Vantelon, J M;
- Bourhis, J H;
- Fenaux, P
Publication type:
journal article
KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 838, doi. 10.1002/hon.3166_OT18
By:
- Cheminant, M.;
- Carras, S.;
- Bruneau, J.;
- Lemonnier, F.;
- Bachy, E.;
- Herbaux, C.;
- Feugier, P.;
- Daguindau, N.;
- Gastinne, T.;
- Guillermin, Y.;
- Lamarque, M.;
- Slama, B.;
- Wolfromm, A.;
- Morschhauser, F.;
- Tournilhac, O.;
- Gaulard, P.;
- Asnafi, V.;
- Ortonne, N.;
- Damaj, G.;
- Hermine, O.
Publication type:
Article
ROMIDEPSIN PLUS CHOP VERSUS CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T‐CELL LYMPHOMA: FINAL ANALYSIS OF THE RO‐CHOP TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 77, doi. 10.1002/hon.3163_41
By:
- Camus, V.;
- Thieblemont, C.;
- Gaulard, P.;
- Cheminant, M.;
- Casasnovas, R.;
- Ysebaert, L.;
- Damaj, G. L.;
- Guidez, S.;
- Pica, G. M.;
- Kim, W. S.;
- Lim, S. T.;
- Andre, M.;
- Gutiérrez, N.;
- Penarrubia, M. J.;
- Staber, P. B.;
- Trotman, J.;
- Hüttmann, A.;
- Stefoni, V.;
- Rossi, G.;
- Delfau‐Larue, M.
Publication type:
Article
Allogeneic transplantation in T‐cell lymphoma: Lessons from the AATT study.
Published in:
Hematological Oncology, 2023, v. 41, p. 512, doi. 10.1002/hon.3164_378
By:
- Tournilhac, O.;
- Altmann, B.;
- Friedrichs, B.;
- Bouabdallah, K.;
- Cartron, G.;
- Nickelsen, M.;
- Wulf, G.;
- Leclerc, M.;
- Vilatte, A.;
- Turlure, P.;
- Sanhès, L.;
- Houot, R.;
- Roussel, M.;
- de Leval, L.;
- Rosenwald, A.;
- Gaulard, P.;
- Dreger, P.;
- Glass, B.;
- Latière, C.;
- Damaj, G.
Publication type:
Article
Quality of life and response shift effect of diffuse large B‐cell lymphoma French patients included in prospective real‐life REALYSA cohort in the first year after diagnosis.
Published in:
Hematological Oncology, 2023, v. 41, p. 428, doi. 10.1002/hon.3164_315
By:
- Anota, A.;
- Basset, M.;
- Belot, A.;
- Bascoul‐Mollevi, C.;
- Cottone, F.;
- Efficace, F.;
- Préau, M.;
- Touraine, C.;
- Damaj, G.;
- Guidez, S.;
- Labouré, G.;
- Lionne‐Huyghe, P.;
- Bonnet, A.;
- Leyronnas, C.;
- Guieze, R.;
- Launay, V.;
- Drenou, B.;
- Fitoussi, O.;
- Detourmignies, L.;
- Soussain, C.
Publication type:
Article
VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 151, doi. 10.1002/hon.3163_100
By:
- Sarkozy, C.;
- Thieblemont, C.;
- Oberic, L.;
- Moreau, A.;
- Bouabdallah, K.;
- Damaj, G.;
- Gastine, T.;
- Ribrag, V.;
- Casasnovas, O.;
- Haioun, C.;
- Houot, R.;
- Jardin, F.;
- Van Den Neste, E.;
- Cheminant, M.;
- Morschhauser, F.;
- Callana, M.;
- Ghesquieres, H.;
- Gressin, R.;
- Hermine, O.;
- Le Gouill, S.
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.57_2880
By:
- Herbaux, C.;
- Schiano de Colella, J. M.;
- Thieblemont, C.;
- Guidez, S.;
- Ysebaert, L.;
- Tilly, H.;
- Le Gouill, S.;
- Houot, R.;
- Bachy, E.;
- Laurent, C.;
- Damaj, G.;
- Feugier, P.;
- Morineau, N.;
- Tarte, K.;
- Morschhauser, F.;
- Cartron, G.
Publication type:
Article
ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.58_2880
By:
- Wang, M.;
- Rule, S.;
- Zinzani, P. L.;
- Goy, A.;
- Casasnovas, O.;
- Smith, S. D.;
- Damaj, G.;
- Doorduijn, J. K.;
- Lamy, T.;
- Morschhauser, F.;
- Panizo, C.;
- Shah, B.;
- Davies, A.;
- Eek, R.;
- Dupuis, J.;
- Jacobsen, E.;
- Kater, A. P.;
- Le Gouill, S.;
- Oberic, L.;
- Robak, T.
Publication type:
Article
EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.5_2879
By:
- Bologna, S;
- Vander Borght, T;
- Briere, J;
- Ribrag, V;
- Damaj, G. L;
- Thieblemont, C;
- Feugier, P;
- Peyrade, F;
- Lebras, L;
- Coso, D;
- Sibon, D;
- Bonnet, C;
- Morschhauser, F;
- Ghesquieres, H;
- Becker, S;
- Olivier, P;
- Fabiani, B;
- Tilly, H;
- Haioun, C;
- Bastie, J. N
Publication type:
Article
CIRCULATING TUMOR DNA LOAD AND TOTAL METABOLIC TUMOR VOLUME IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) PATIENTS TREATED BY R‐CHOP – FROM REMARC, A LYSA STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.3_2880
By:
- Bohers, E;
- Delfau‐Larue, M;
- Vercellino, L;
- Cottereau, A;
- Viennot, M;
- Viailly, P;
- Salles, G;
- Tilly, H;
- Damaj, G;
- Haioun, C;
- Ribrag, V;
- Morschhauser, F;
- Casasnovas, R;
- Nicolas‐Virelizier, E;
- Feugier, P;
- Bouabdallah, R;
- Cartron, G;
- Renaud, L;
- Chartier, L;
- Portugues, C
Publication type:
Article
CHARACTERISTICS OF PATIENTS ACHIEVING COMPLETE OR PARTIAL RESPONSE (CR/PR) WITH TAZEMETOSTAT (TAZ) IN WILD‐TYPE RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.21_2880
By:
- Batlevi, C. L.;
- Salles, G.;
- Tilly, H.;
- Chaidos, A.;
- McKay, P.;
- Phillips, T.;
- Assouline, S.;
- Campbell, P.;
- Ribrag, V.;
- Damaj, G. Laurent;
- Dickinson, M.;
- Jurczak, W.;
- Kaźmierczak, M.;
- Opat, S.;
- Radford, J. R.;
- Schmitt, A.;
- Rajarethinam, A.;
- Shang, G.;
- Morschhauser, F.
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.22_2880
By:
- Cartron, G.;
- Bachy, E.;
- Guidez, S.;
- Gyan, E.;
- Gressin, R.;
- Morineau, N.;
- Sibon, D.;
- Casasnovas, O.;
- Le Gouill, S.;
- Tilly, H.;
- Ysebaert, L.;
- Schiano de Colella, J. M.;
- Feugier, P.;
- Virelizier, E. Nicolas;
- Haioun, C.;
- Damaj, G.;
- Tarte, K.;
- Laurent, C.;
- Houot, R.;
- Thieblemont, C.
Publication type:
Article
IMPACT OF DUSP22 REARRANGEMENT ON THE PROGNOSIS OF SYSTEMIC ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A LYSA AND TENOMIC STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.137_2880
By:
- Sibon, D;
- Bisig, B;
- Bonnet, C;
- Bachy, E;
- Cavalieri, D;
- Fataccioli, V;
- Drieux, F;
- Bruneau, J;
- Lemonnier, F;
- Bossard, C;
- Bouabdallah, K;
- Parrens, M;
- Damaj, G;
- Tournilhac, O;
- Jais, J. P;
- Gaulard, P;
- de Leval, L
Publication type:
Article
OUTCOME AND TREATMENT OF RELAPSING EARLY PET NEGATIVE PATIENTS INCLUDED IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 294, doi. 10.1002/hon.104_2630
By:
- Gac, A.;
- Chartier, L.;
- Girinsky, T.;
- Gotti, M.;
- Lazarovici, J.;
- Aurer, I.;
- Musto, P.;
- Damaj, G.;
- Federico, M.;
- Fortpied, C.;
- Raemaekers, J.;
- Meignan, M.;
- Hutchings, M.;
- Versati, A.;
- Andre, M.;
- Reman, O.
Publication type:
Article
OUTCOME AND TREATMENT OF RELAPSING EARLY PET NEGATIVE PATIENTS INCLUDED IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 294, doi. 10.1002/hon.104_2630
By:
- Gac, A.;
- Chartier, L.;
- Girinsky, T.;
- Gotti, M.;
- Lazarovici, J.;
- Aurer, I.;
- Musto, P.;
- Damaj, G.;
- Federico, M.;
- Fortpied, C.;
- Raemaekers, J.;
- Meignan, M.;
- Hutchings, M.;
- Versati, A.;
- Andre, M.;
- Reman, O.
Publication type:
Article
FIRST LINE TREATMENT BY THE RIBVD REGIMEN ELICITS HIGH CLINICAL AND MOLECULAR RESPONSE RATES AND PROLONGED SURVIVAL IN ELDERLY MCL PATIENTS; FINAL RESULTS OF a LYSA GROUP TRIAL.
Published in:
Hematological Oncology, 2017, v. 35, p. 141, doi. 10.1002/hon.2437_131
By:
- Gressin, R.;
- Daguindau, N.;
- Tempescul, A.;
- Moreau, A.;
- Carras, S.;
- Cartron, G.;
- Schmitt, A.;
- Houot, R.;
- Dartigeas, C.;
- Pignon, J.;
- Corm, S.;
- Bannos, A.;
- Mounier, C.;
- Dupuis, J.;
- Macro, M.;
- Fleury, J.;
- Jardin, F.;
- Karlin, L.;
- Damaj, G.;
- Feugier, P.
Publication type:
Article
ROLE OF UP-FRONT AUTOLOGOUS STEM CELL TRANSPLANTATION IN PERIPHERAL T-CELL LYMPHOMAS: a PROPENSITY SCORE MATCHING ANALYSIS OF PATIENTS FROM LYSA CENTERS.
Published in:
Hematological Oncology, 2017, v. 35, p. 76, doi. 10.1002/hon.2437_64
By:
- Fossard, G.;
- Broussais, F.;
- Coelho, I.;
- Bailly, S.;
- Nicolas ‐ Virelizier, E.;
- Toussaint, E.;
- Lancesseur, C.;
- Lebras, F.;
- Willems, E.;
- Tchernonog, E.;
- Delarue, R.;
- Gressin, R.;
- Chauchet, A.;
- Gyan, E.;
- Cartron, G.;
- Bonnet, C.;
- Haioun, C.;
- Damaj, G.;
- Gaulard, P.;
- Fornecker, L.
Publication type:
Article
Rituximab maintenance after autologous stem-cell transplantation in patients with mantle cell lymphoma, final result of the LyMA trial conducted on behalf the LYSA group.
Published in:
Hematological Oncology, 2017, v. 35, p. 209, doi. 10.1002/hon.2438_74
By:
- Le Gouill, S.;
- Thieblemont, C.;
- Oberic, L.;
- Moreau, A.;
- Bouabdallah, K.;
- Dartigeas, C.;
- Damaj, G.;
- Gastinne, T.;
- Ribrag, V.;
- Feugier, P.;
- Casasnovas, O.;
- Zerazhi, H.;
- Haioun, C.;
- Maisonneuve, H.;
- Van Den Neste, E.;
- Tournilhac, O.;
- Le Dû, K.;
- Morschhauser, F.;
- Cartron, G.;
- Fornecker, L.
Publication type:
Article
R-CHOP +/-RADIOTHERAPY IN NON-BULKY LIMITED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): FINAL RESULTS OF THE PROSPECTIVE RANDOMIZED PHASE III 02-03 TRIAL FROM THE LYSA/GOELAMS.
Published in:
Hematological Oncology, 2017, v. 35, p. 128, doi. 10.1002/hon.2437_118
By:
- Lamy, T.;
- Damaj, G.;
- Soubeyran, P.;
- Gyan, E.;
- Legouill, S.;
- Cartron, G.;
- Boubdallah, K.;
- Gressin, R.;
- Cornillon, J.;
- Banos, A.;
- Ledu, K.;
- Benchalal, M.;
- Moles, M.;
- Fleury, J.;
- Godmer, P.;
- Maisonneuve, H.;
- Deconninck, E.;
- Laribi, K.;
- Marolleau, J.;
- Tournilhac, O.
Publication type:
Article

Found: 55